Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.
about
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocolAcute lymphoblastic leukaemiaNew and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemiaGenetic abnormalities associated with acute lymphoblastic leukemiaOncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesTranslating cancer genomes and transcriptomes for precision oncologyJAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indicationsDiagnosis and subclassification of acute lymphoblastic leukemiaRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineA health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigmCurrent concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemiaRecurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaChildhood acute lymphoblastic leukemia: Integrating genomics into therapyPrognostification of ALL by CytogeneticsChildhood Acute Lymphoblastic Leukemia: Progress Through Collaboration12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitorsCo-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunctionUse of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemiaCross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal CancerMulti-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemiaCONSERTING: integrating copy-number analysis with structural-variation detection.Targeting substrate-site in Jak2 kinase prevents emergence of genetic resistanceIntegration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray studySpaced Seed Data Structures for De Novo Assembly.MOSAIK: a hash-based algorithm for accurate next-generation sequencing short-read mapping.Solving the genetic puzzle of systemic lupus erythematosus.Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia.ABySS 2.0: resource-efficient assembly of large genomes using a Bloom filter.Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subsetManagement of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.Childhood B-acute lymphoblastic leukemia: a genetic update.Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.
P2860
Q23749304-E3346A3B-7A58-4944-BFFF-D71255522B9BQ24602387-E8877DA8-04CB-4CF4-96BA-651CACB32893Q26749177-979F8CEB-B310-4077-B07C-6E9393121EA3Q26753823-82F7621B-AD4C-4273-9098-13C109401275Q26768158-F08C2396-9E4C-4991-8D5B-4FD932252196Q26777081-20606E02-1945-4F00-9C95-CE6B5AF75786Q26782539-632BBBC5-8905-4EB8-8C00-63E7B7391973Q26824387-4DF7E624-1D44-4489-A8A6-356A8918637AQ26864460-862A9D75-AEB4-452A-B829-D9CA260125E1Q26866379-C6A9BE88-5838-445A-9984-59362BEA4A09Q27025242-D4FFBF91-E266-4CF1-9279-0AA0E12F62DBQ27853366-F0E352C7-CD48-4030-B0B4-5358D407662EQ27853385-45CCEEA7-7FDA-4F5D-BDF2-DFCAF21C134EQ28080463-A562C42D-CCFB-40C8-AF18-2631EDB8551EQ28087446-5563FDBD-45AD-4FE6-8C74-AE531FEBE790Q28087637-7EC3465B-A1B1-4573-AEF1-B092B9D8DACFQ28242134-137825D4-4AC0-4B77-831A-4A6ED4829B87Q28274115-F3E2C4A5-64BF-4029-AF5D-7FE087059F2BQ28276513-689164F8-2FDD-43B0-9CE1-83C649B46CE2Q28390558-499ACC94-1617-434F-BABA-77A10265FD61Q28396029-01E20770-25B8-4C2C-9DF9-D9EBCB4061EBQ28541556-40C26B6F-B2FC-4F5B-92AF-A7D43919EF91Q30397544-60035DB2-D13B-4112-BF51-9E91B1FB2E12Q30666276-ABA7875B-1507-46DB-AAE9-D11C545A4909Q30842603-8B4D83B7-B76C-420B-B701-4681A3252ED6Q31018280-029EF503-4743-44FE-BEFA-6510D82F7E03Q31153287-29EEAEF3-D0E0-446E-A7FA-A12905BD43D7Q33359121-D21BADD3-1D52-4578-9268-16B062C395D9Q33422654-DE9F9BE9-0AEF-4591-958B-FEE26ED094B5Q33573735-4031BBD7-B3F3-46A8-9C83-AF00B945B328Q33578333-5C0CD89F-F3B8-450A-A4F5-5EC7FB884709Q33586588-EA0786CC-B843-4830-8FDA-1C1E4B9A6710Q33622598-103F07D3-B040-46B6-8ACE-2F1C7B8AD2EDQ33688248-E7949FEF-D985-4319-8EB7-EEDD05FA5FDEQ33695967-947DB283-3D87-4F23-835D-7D103A38251FQ33711119-4FC0E116-5893-4AF7-A7C6-CE277836EFA4Q33728277-DCBB71CD-9F87-4A9E-B9E8-3126B931C0BCQ33762835-86F15D9B-1DE7-465D-9294-58E8F67F9422Q33777616-7BAA6C13-AD56-45BD-ADFA-C569DD815D2BQ33789597-B7B49138-2B46-41C7-BBE5-119B5EAB2388
P2860
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Genetic alterations activating ...... acute lymphoblastic leukemia.
@ast
Genetic alterations activating ...... acute lymphoblastic leukemia.
@en
type
label
Genetic alterations activating ...... acute lymphoblastic leukemia.
@ast
Genetic alterations activating ...... acute lymphoblastic leukemia.
@en
prefLabel
Genetic alterations activating ...... acute lymphoblastic leukemia.
@ast
Genetic alterations activating ...... acute lymphoblastic leukemia.
@en
P2093
P2860
P50
P1433
P1476
Genetic alterations activating ...... acute lymphoblastic leukemia.
@en
P2093
Cheryl L Willman
Chunhua Yan
Corynn Kasap
Daniela S Gerhard
David T Teachey
Debbie Payne-Turner
Eric Larsen
Gregory Reaman
Guillermo Garcia-Manero
I-Ming Chen
P2860
P304
P356
10.1016/J.CCR.2012.06.005
P50
P577
2012-08-01T00:00:00Z